CancerIQ is a digital health company that is lowering barriers to personalize cancer care. CancerIQ empowers your everyday doctor with the knowledge and skills needed to deliver cancer risk assessment, prevention, and genetically-informed treatment. Cofounded by Feyi Olopade, Moe Alkhafaji, Haibo Lu, and Olufunmilayo Olopade in 2013, the team assembled to solve the growing problem of patient success. With this in mind, the company opted to compete in the 2013 Edward L. Kaplan, ’71, New Venture Challenge (NVC) and took home $10,000 after placing fourth. Today, CancerIQ offers capabilities in diverse practice settings such as breast centers, genetics practices, and OBGYN making it easy for providers to offer geneticapp cancer risk assessment programming to every patient. Follow @CancerIQ as they make strides in the healthcare industry to grow highly impactful cancer programs at lower costs.
- Founded by Feyi Olopade, Moe Alkhafaji, Haibo Lu, and Olufunmilayo Olapade
- 4th place at the 2013 NVC ($10,000)
- Headquartered in Chicago, IL